# Filing Detail

Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-19-289953
Filing Date
2019-11-12
Accepted
2019-11-12 16:14:43
Documents
26

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 424B4 | d743471d424b4.htm | 424B4 | 1775996
2 | GRAPHIC | g743471g04x51.jpg | GRAPHIC | 75384
3 | GRAPHIC | g743471g05y72.jpg | GRAPHIC | 78153
4 | GRAPHIC | g743471g06p27.jpg | GRAPHIC | 79805
5 | GRAPHIC | g743471g07o50.jpg | GRAPHIC | 77309
6 | GRAPHIC | g743471g07v49.jpg | GRAPHIC | 67821
7 | GRAPHIC | g743471g10p10.jpg | GRAPHIC | 111876
8 | GRAPHIC | g743471g11f23.jpg | GRAPHIC | 85615
9 | GRAPHIC | g743471g11t11.jpg | GRAPHIC | 73473
10 | GRAPHIC | g743471g13p07.jpg | GRAPHIC | 120997
11 | GRAPHIC | g743471g16b74.jpg | GRAPHIC | 125888
12 | GRAPHIC | g743471g17p84.jpg | GRAPHIC | 157814
13 | GRAPHIC | g743471g17u63.jpg | GRAPHIC | 76098
14 | GRAPHIC | g743471g31c65.jpg | GRAPHIC | 99918
15 | GRAPHIC | g743471g32d67.jpg | GRAPHIC | 87979
16 | GRAPHIC | g743471g36i06.jpg | GRAPHIC | 27684
17 | GRAPHIC | g743471g40l24.jpg | GRAPHIC | 153877
18 | GRAPHIC | g743471g41c25.jpg | GRAPHIC | 79177
19 | GRAPHIC | g743471g41g83.jpg | GRAPHIC | 96071
20 | GRAPHIC | g743471g45e83.jpg | GRAPHIC | 96303
21 | GRAPHIC | g743471g46x01.jpg | GRAPHIC | 67878
22 | GRAPHIC | g743471g62l42.jpg | GRAPHIC | 74268
23 | GRAPHIC | g743471g67c45.jpg | GRAPHIC | 214805
24 | GRAPHIC | g743471g74s65.jpg | GRAPHIC | 175192
25 | GRAPHIC | g743471g75o60.jpg | GRAPHIC | 113908
26 | GRAPHIC | g743471g89o26.jpg | GRAPHIC | 102890
| Complete submission text file | 0001193125-19-289953.txt |  | 5252136

Mailing Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105
Business Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105 4155004614
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

EIN.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-234174 | Film No.: 191209572
SIC: 2834 Pharmaceutical Preparations